Genentech (RHHBY) to Make 60+ Presentations at ASH 2016; Will Include Phase III GALLIUM Study Data

November 3, 2016 12:39 PM

Genentech, a member of the Roche Group (OTC: RHHBY), announced that more than 60 abstracts featuring nine of its approved ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found